U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07164326) titled 'Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation in Sever Preeclamptic Patients' on Aug. 30.
Brief Summary: Dexmedetomidine nebulization in sever preeclamptic patients
Study Start Date: Oct. 15
Study Type: INTERVENTIONAL
Condition:
Pressor Response
Intervention:
DRUG: Dexmedetomidine
Nebulization of dexmedetomidine
DRUG: Saline
Nebulization of normal saline
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Responsible Party): Mohamed Sayed Hussein Hassan, Assiut University
Published by HT Digital Content Services with p...